Clinical Trials

40 enrolled

Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT07607925 2026-05-27

A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

49 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT07609823 2026-05-27

A Phase 2 Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL

LymphoidOther hematologic neoplasm

75 enrolled

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07607327 2026-05-26

FORWARD

Classical hematologyOther hematologic neoplasm

400 enrolled

Anemia, Refractory, with Excess of Blasts, Recurrence, Leukemia, Myeloid, Acute

NCT07601607 2026-05-22

Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma

51 enrolled

Phase NA Not yet recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT07198945 2026-05-14

STARLING

546 enrolled

Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps, Neoplasm Recurrence, Local, Recurrence

NCT07586618 2026-05-14

ALT-101

LymphoidOther hematologic neoplasm

24 enrolled

Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07572695 2026-05-07

Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

40 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Recurrence, Leukemia, Myeloid, Acute

NCT07574346 2026-05-07

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

18 enrolled

Neoplasms, Recurrence

NCT07570407 2026-05-06

QiNKT-HSCT

75 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT06970496 2026-05-05

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

48 enrolled

Recurrence, Lymphoma, B-Cell

NCT07567469 2026-05-05

A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

120 enrolled

CNS

Ependymoma, Glioma, Neoplasms, Recurrence

NCT07542717 2026-04-21

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

41 enrolled

Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT07543055 2026-04-21

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

36 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT07453095 2026-04-17

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

41 enrolled

Recurrence, Lymphoma, Mantle-Cell

NCT07535710 2026-04-17

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

37 enrolled

DermatologicLymphoid

Recurrence, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

120 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07532746 2026-04-16

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

55 enrolled

Recurrence, Hematologic Neoplasms

NCT07493174 2026-04-15

Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies

86 enrolled

Recurrence

NCT07521670 2026-04-13

STRAP

Phase EARLY_PHASE1 Not yet recruiting

68 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence

NCT07519187 2026-04-09

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

20 enrolled

Plasma cell

Recurrence, Neoplasms, Plasma Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT07510100 2026-04-03

FUMANBA-04

17 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT07502768 2026-03-31

EpiRev-NKT

107 enrolled

Recurrence, Lymphoma, Extranodal NK-T-Cell

NCT07484763 2026-03-20

Predicting Recurrence in HR+/HER2- Early Breast Cancer

500 enrolled

Breast

Breast Neoplasms, Recurrence

NCT07485504 2026-03-20

Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies

15 enrolled

Phase NA Not yet recruiting

Recurrence, Hematologic Neoplasms

NCT07478705 2026-03-17

EINSTEIN-TNBC

30 enrolled

Breast

Recurrence, Triple Negative Breast Neoplasms

NCT07470294 2026-03-13

PiloPedia

90 enrolled

Pilonidal Sinus, Recurrence

NCT06639607 2026-03-10

PRiME II

68 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

NCT07458204 2026-03-09

EPPIL

760 enrolled

Breast

Recurrence, Triple Negative Breast Neoplasms

NCT07448376 2026-03-04

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

20 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT07444918 2026-03-03

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors